Journal Of Experimental & Clinical Cancer Research

Journal Of Experimental & Clinical Cancer Research

实验与临床癌症研究杂志

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Journal Of Experimental & Clinical Cancer Research》是由BioMed Central出版社于2008年创办的英文国际期刊(ISSN: 1756-9966,E-ISSN: 1756-9966),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比87.50%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在280篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Experimental & Clinical Cancer Research审稿周期约为 约1月 。该刊近年未被列入国际预警名单,年发文量约280篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 280 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 25 / 322

92.4%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 21 / 322

93.63%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:18.2 SJR:2.806 SNIP:1.77
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 23 / 404

94%

大类:Medicine 小类:Cancer Research Q1 16 / 230

93%

期刊发文

  • LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization

    Author: Zhang, Nasha; Wang, Bowen; Ma, Chi; Zeng, Jiajia; Wang, Teng; Han, Linyu; Yang, Ming

    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02654-9

  • FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling

    Author: Yang, Yiqi; Zhang, Yibo; Cao, Jieqiong; Su, Zijian; Li, Fu; Zhang, Peiguang; Zhang, Bihui; Liu, Rongzhan; Zhang, Linhao; Xie, Junye; Li, Jingsheng; Zhang, Jinting; Chen, Xiaojia; Hong, An

    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02659-4

  • Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth

    Author: Jia, Xuechao; Wang, Penglei; Huang, Chuntian; Zhao, Dengyun; Wu, Qiong; Lu, Bingbing; Nie, Wenna; Huang, Limeng; Tian, Xueli; li, Pan; Laster, Kyle Vaughn; Jiang, Yanan; Li, Xiang; Li, Honglin; Dong, Zigang; Liu, Kangdong

    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02666-5

  • Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development

    Author: Gao, Lixia; Yang, Fan; Tang, Dianyong; Xu, Zhigang; Tang, Yan; Yang, Donglin; Sun, Deping; Chen, Zhongzhu; Teng, Yong

    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02574-0

  • KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2

    Author: Zhou, Hui; Chen, Junru; Fan, Mingjie; Cai, Huajian; Dong, Yufei; Qiu, Yue; Zhuang, Qianqian; Lei, Zhaoying; Li, Mengyao; Ding, Xue; Yan, Peng; Lin, Aifu; Zheng, Shusen; Yan, Qingfeng

    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02562-4

  • S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma

    Author: Wang, Xingtong; Guo, Wei; Shi, Xiaoju; Chen, Yujia; Yu, Youxi; Du, Beibei; Tan, Min; Tong, Li; Wang, Anna; Yin, Xianying; Guo, Jing; Martin, Robert C. C.; Bai, Ou; Li, Yan

    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02589-7

  • Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis

    Author: Li, Yan; Yang, Wenjuan; Zheng, Yuanyuan; Dai, Weiqi; Ji, Jie; Wu, Liwei; Cheng, Ziqi; Zhang, Jie; Li, Jingjing; Xu, Xuanfu; Wu, Jianye; Yang, Mingwei; Feng, Jiao; Guo, Chuanyong

    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02567-z

  • Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression

    Author: Deng, Min; Zhang, Long; Zheng, Wenying; Chen, Jiale; Du, Nan; Li, Meiqi; Chen, Weiqing; Huang, Yonghong; Zeng, Ning; Song, Yuanbin; Chen, Yongming

    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02586-w